ArticleOpen medicine (Warsaw, Poland)2025
A machine learning-based prognostic model integrating mRNA stemness index, hypoxia, and glycolysis‑related biomarkers for colorectal cancer.
Article in Open medicine (Warsaw, Poland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cancer stemness, hypoxia, and glycolysis collectively influence colorectal cancer (CRC) progression. However, the intricate relationships among these factors remain incompletely understood. Methods: This study (1) explored hypoxia and glycolysis-related genes (HGRGs) in CRC by mRNA stemness index (mRNAsi), analyzed the gene expression profiles from Gene Expression Omnibus and The Cancer Genome Atlas (TCGA) databases, (2) established a Cox-prognostic model based on single-sample gene set enrichment analysis, differentially expressed gene analysis, weighted gene co-expression network analysis, and Least Absolute Shrinkage and Selection Operator (LASSO) and Cox regression analyses, and (3) assessed the predictive accuracy of the model. Decision curve analysis (DCA) was employed to determine the clinical utility of the model. Results: Ten HGRGs were selected based on mRNAsi to create the LASSO model. High-risk CRC patients in the TCGA dataset displayed unfavorable clinical outcomes and responses to immunotherapy. Consensus cluster analysis revealed two distinct colon adenocarcinoma/rectal adenocarcinoma clusters, with patients in cluster 2 having a worse prognosis compared to patients in cluster 1. A five-gene prognostic nomogram was developed through univariate and multivariate Cox regression analyses, with DCA confirming its accuracy. Conclusions: This innovative prognostic model, incorporating
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.